EC 1.5.1.3

CAS No.
Chemical Name:
EC 1.5.1.3
Synonyms
DHFR;EC 1.5.1.3;DIHYDROFOLATE REDUCTASE;DIHYDROFOLATE REDUCTASE HUMAN;TETRAHYDROFOLATE DEHYDROGENASE;TETRAHYDROFOLATE NADP+ OXIDOREDUCTASE;DHFR, Tetrahydrofolate NADP+ oxidoreductase
CBNumber:
CB4114482
Molecular Formula:
Molecular Weight:
0
MDL Number:
MFCD00130955
MOL File:
Mol file
Last updated:2022-12-21 16:56:50

EC 1.5.1.3 Properties

storage temp. −20°C
FDA UNII 5T4JAQ7QVD

SAFETY

Risk and Safety Statements

WGK Germany  3

EC 1.5.1.3 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Usbiological 396382 DHFR 48Tests $588 2021-12-16 Buy
Biorbyt Ltd orb595997 DHFR 10μg $290.7 2021-12-16 Buy
Product number Packaging Price Buy
396382 48Tests $588 Buy
orb595997 10μg $290.7 Buy

EC 1.5.1.3 Chemical Properties,Uses,Production

Uses

Human dihydrofolate reductase has been used in a study to investigate the stable expression of green fluorescent protein and the targeted disruption of thioredoxin peroxidase-1 gene in Babesia bovis. Human dihydrofolate reductase has also been used in a study to investigate the structural analysis of human dihydrofolate reductase as a binary complex.

General Description

Human DHFR is an 186 amino acid protein with an apparent molecular weight of 25 kDa. It is 30% homologous to the E. coli protein and up to 70% homologous to vertebrate proteins.

Biochem/physiol Actions

The human DHFR gene, as well as DHFR genes in other mammalian species, overcome the inhibitory effects of methotrexate by a mechanism of gene amplification or by amino-acid mutagenesis. Dihydroflate reductase (DHFR) catalyzes the NADPH dependent reduction of dihydrofolate (DHF) to tetrahydrofolate (THF) and, at a much lower rate, the conversion of folate to THF. The reaction product, THF, is an essential cofactor in the conversion of deoxyuridylate (dUMP) to deoxythymidylate (dTMP) by thymidylate synthetase. It is a key enzyme in thymidine synthesis. Therefore, DHFR is a critical enzyme in DNA synthesis and has become a target for drug development and cancer therapy. The variations between DHFR from different sources have enabled the development of species selective DHFR inhibitors, such as trimethoprim (antibacterial and antifungal), pyrimethamine (antiprotozoal), and methotrexate; MTX (antineoplastic, antipsoriatic, and anti-inflammatory).

EC 1.5.1.3 Preparation Products And Raw materials

Raw materials

Preparation Products

EC 1.5.1.3 Suppliers

Global( 15)Suppliers
Supplier Tel Email Country ProdList Advantage
Guangzhou Tomums Life Science Co., Ltd. 020-31155029 18902330969 sales@tomums.cn China 4698 58
Shanghai Yaji Biological Technology Co., Ltd. 021-34661275 15301693058 yajikit@163.com China 9592 58
DIHYDROFOLATE REDUCTASE DIHYDROFOLATE REDUCTASE HUMAN EC 1.5.1.3 DHFR TETRAHYDROFOLATE DEHYDROGENASE TETRAHYDROFOLATE NADP+ OXIDOREDUCTASE DHFR, Tetrahydrofolate NADP+ oxidoreductase